Recombinomics | Elegant Evolution






Home Founder What's New In The News Contact Us





























Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Audio:  Jan28   Apr21  Sep22  Nov10     RSS Feed    News Now                         

Commentary

H1N1 Tamiflu Resistance in Norway
Recombinomics Commentary 12:57
November 14, 2008

Five of the six A(H1N1) viruses were shown to be resistant to oseltamivir (4 from the UK and 1 from Norway) and one to be sensitive; all those tested against zanamivir (4) and amantadine (2) were shown to be sensitive.

The above comments from the week 45 report on seasonal flu in Europe add Norway to the list of countries where the first H1N1 tested this season had H274Y.  The tally thus far is 9/10 in UK, 1/1 in Canada, and 1/1 in Norway.

Since the first H1N1 isolate reported in Norway this season was from a traveler who had returned from the United States, the H274Y in this sample may reflect levels in the US this season.

As the list grows, it becomes increasing clear that the level of H274Y in H1N1 isolates from Europe and North America will be at or near 100% in many countries.

These levels are consistent withy H274Y levels in countries reporting during the 2008 flu season in the summer hemisphere, providing more evidence on the predictability of northern hemisphere activity by activity in preceding season in the southern hemisphere.

Media Links

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings
















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2008 Recombinomics.  All rights reserved.